CPHI China Pharma Holdings Inc.

China Pharma Holding Inc is mainly engaged in the development, manufacture and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in China.

$0.72
As of 06/18/2021     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  USA
Country of incorporation:  
IPO date:  02/11/2013
Outstanding shares:  43,579,557
Average volume:  1,773,079
Market cap:   $31,377,281
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    16941T104
ISIN:        
Sedol:      
Valuation   (See tab for details)
PE ratio:   -10.55
PB ratio:   1.15
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy